ABBV Shares Outstanding History
Below is a table of the ABBV shares outstanding history going back to 1/31/2013:

Date ABBV Shares Outstanding
1/31/20131.58B
3/31/20131.58B
6/30/20131.59B
9/30/20131.59B
1/31/20141.59B
3/31/20141.59B
6/30/20141.59B
9/30/20141.59B
1/31/20151.59B
3/31/20151.59B
6/30/20151.66B
9/30/20151.63B
1/31/20161.61B
3/31/20161.62B
6/30/20161.63B
10/24/20161.63B
1/31/20171.59B
4/24/20171.59B
7/24/20171.59B
10/24/20171.60B
2/2/20181.59B
4/27/20181.59B
7/31/20181.51B
10/31/20181.50B
2/8/20191.48B
4/26/20191.48B
7/29/20191.48B
3/6/201823.95M
10/29/20191.48B
1/31/20201.48B
4/30/20201.48B
7/28/20201.76B
10/27/20201.77B
1/31/20211.77B
4/28/20211.77B
7/26/20211.77B

Also see: ABBV Market Cap History
ABBV YTD Return
ABBV RSI
ABBV DMA
ABBV MACD
ABBV Technical Analysis
ABBV Historical Shares Outstanding:
+1.35% CAGR
ABBV Historical Shares Outstanding: +1.35% CAGR

Mouse over chart for data details
1/31/2013 ...7/26/2021
AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid. We show 36 historical shares outstanding datapoints in our coverage of ABBV's shares outstanding history.

Understanding the changing numbers of ABBV shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ABBV versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ABBV by allowing them to research ABBV shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ABBV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AbbVie (ABBV) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ABC Shares Outstanding History
ABEO Shares Outstanding History
ABIO Shares Outstanding History
ABMD Shares Outstanding History
ABOS Shares Outstanding History
ABSI Shares Outstanding History
ABT Shares Outstanding History
ABVC Shares Outstanding History
ACAD Shares Outstanding History
ACCD Shares Outstanding History
More Healthcare companies »

 

ABBV Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.